Preventing tuberculosis with community-based care in an HIV-endemic setting: a modeling analysis

Author:

Ross Jennifer M.ORCID,Greene Chelsea,Bayer Cara J.,Dowdy David W.,van Heerden Alastair,Heitner Jesse,Rao Darcy W.,Roberts D. Allen,Shapiro Adrienne E.ORCID,Zabinsky Zelda B.,Barnabas Ruanne V.

Abstract

AbstractIntroductionAntiretroviral therapy (ART) and TB preventive treatment (TPT) both prevent tuberculosis (TB) disease and deaths among people living with HIV. Differentiated care models, including community-based care, can increase uptake of ART and TPT to prevent TB in settings with a high burden of HIV-associated TB, particularly among men.MethodsWe developed a gender-stratified dynamic model of TB and HIV transmission and disease progression among 100,000 adults ages 15-59 in KwaZulu-Natal, South Africa. We drew model parameters from a community-based ART initiation and resupply trial in sub-Saharan Africa (Delivery Optimization for Antiretroviral Therapy, DO ART) and other scientific literature. We simulated the impacts of community-based ART and TPT care programs during 2018-2027, assuming that community-based ART and TPT care were scaled up to similar levels as in the DO ART trial (i.e., ART coverage increasing from 49% to 82% among men and from 69% to 83% among women) and sustained for ten years. We projected the number of TB cases, deaths, and disability-adjusted life years (DALYs) averted relative to standard, clinic-based care. We calculated program costs and incremental cost-effectiveness ratios from the provider perspective.ResultsIf community-based ART care could be implemented with similar effectiveness to the DO ART trial, increased ART coverage could reduce TB incidence by 27.0% (range 21.3% - 34.1%) and TB mortality by 36.0% (range 26.9% - 43.8%) after ten years. Increasing both ART and TPT uptake through community-based ART with TPT care could reduce TB incidence by 29.7% (range 23.9% - 36.0%) and TB mortality by 36.0% (range 26.9% - 43.8%). Community-based ART with TPT care reduced gender disparities in TB mortality rates by reducing TB mortality among men by a projected 39.8% (range 32.2% - 46.3%) and by 30.9% (range 25.3% - 36.5%) among women. Over ten years, the mean cost per DALY averted by community-based ART with TPT care was $846 USD (range $709 - $1,012).ConclusionsBy substantially increasing coverage of ART and TPT, community-based care for people living with HIV could reduce TB incidence and mortality in settings with high burdens of HIV-associated TB and reduce TB gender disparities.

Publisher

Cold Spring Harbor Laboratory

Reference72 articles.

1. World Health Organization. Global Tuberculosis Report. 2022.

2. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic;Arch Intern Med [Internet],2003

3. Moyo S , Ismail F , Van der Walt M , Ismail N , Mkhondo N , Dlamini S , et al. Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey. Lancet Infect Dis [Internet]. 2022 May 17; Available from: http://www.ncbi.nlm.nih.gov/pubmed/35594897

4. Human Sciences Research Council. South African National HIV Prevalence, Incidence, Behaviour and Communication survey, 2017. Towards achieving the UNAIDS 90-90-90 targets. 2019 Oct.

5. Ledesma JR , Ma J , Vongpradith A , Maddison ER , Novotney A , Biehl MH , et al. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis [Internet]. 2021 Sep; Available from: https://linkinghub.elsevier.com/retrieve/pii/S1473309921004497

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3